WHITEBOX ADVISORS LLC - ONYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WHITEBOX ADVISORS LLC ownership history of ONYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$76,525,000
+40.0%
23,848,0000.0%4.04%
+40.6%
Q2 2013$54,659,00023,848,0002.87%
Other shareholders
ONYX PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 51,697,000$118,859,00012.48%
Raven Rock Credit Master Fund L.P. 1,000,000$2,277,0003.87%
WHITEBOX ADVISORS LLC 23,848,000$54,659,0002.87%
SYMPHONY ASSET MANAGEMENT LLC 9,250,000$21,061,0002.03%
ANGELO GORDON & CO., L.P. 10,000,000$22,769,0001.63%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 37,119,000$84,515,0000.84%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 8,850,000$20,226,000,0000.38%
Man Investments (CH) AG 150,000$343,0000.17%
PALISADE CAPITAL MANAGEMENT, LP 2,500,000$5,712,0000.16%
D. E. Shaw & Co., Inc. 30,580,000$69,729,0000.13%
View complete list of ONYX PHARMACEUTICALS INC shareholders